Removal of advanced glycation end products in clinical renal failure by peritoneal dialysis and haemodialysis.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Biochemical Society Transactions

• Publication date

  2003-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1042/BST0311394PMID 14641071
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine.

  2003cited by this paper
• The Maillard reaction in food chemistry and medical science: Update for the postgenomic era

  2002cited by this paper
• Glyoxalase I deficiency is associated with an unusual level of advanced glycation end products in a hemodialysis patient.

  2001cited by this paper
• Accumulation of alpha-oxoaldehydes during oxidative stress: a role in cytotoxicity.

  1999cited by this paper
• Increase in three alpha,beta-dicarbonyl compound levels in human uremic plasma: specific in vivo determination of intermediates in advanced Maillard reaction.

  1999cited by this paper
• 3-Deoxyglucosone, a Promoter of Advanced Glycation end Products in Fluids for Peritoneal Dialysis

  1998cited by this paper
• Imidazolium crosslinks derived from reaction of lysine with glyoxal and methylglyoxal are increased in serum proteins of uremic patients: evidence for increased oxidative stress in uremia

  1998cited by this paper
• Technical note. The serum concentration of the advanced glycation end-product N epsilon-(carboxymethyl)lysine is increased in uremia.

  1997cited by this paper
• Possible Significance of Advanced Glycation End Products in Serum in End-Stage Renal Disease and in Late Complications of Diabetes

  1996cited by this paper
• Kidney transplantation decreases the tissue level of advanced glycosylation end-products.

  1995cited by this paper
• Immunological quantification of advanced glycosylation end-products in the serum of patients on hemodialysis or CAPD.

  1994cited by this paper
• Immune system dysregulation in uremia.

  1994cited by this paper
• Identity of a major 3-deoxyglucosone-reducing enzyme with aldehyde reductase in rat liver established by amino acid sequencing and cDNA expression.

  1993cited by this paper
• Glycated albumin in serum and dialysate of patients on continuous ambulatory peritoneal dialysis.

  1993cited by this paper
• The glyoxalase system in health and disease.

  1993cited by this paper
• Advanced glycosylation end products in patients with diabetic nephropathy.

  1991cited by this paper

• Association between advanced glycation end products and estimated glomerular filtration rate: a cross-sectional analysis

  2025cites this paper
• The Potential Role of Advanced Glycation End Products in the Development of Kidney Disease

  2025cites this paper
• Advanced Glycation End Products (AGEs) and Chronic Kidney Disease: Does the Modern Diet AGE the Kidney?

  2022cites this paper
• Crocin attenuates methylglyoxal-induced osteoclast dysfunction by regulating glyoxalase, oxidative stress, and mitochondrial function.

  2019cites this paper
• Free Pentosidine Assessment Based on Fluorescence Measurements in Spent Dialysate

  2018cites this paper
• The clinical usefulness of glycated albumin in patients with diabetes and chronic kidney disease: Progress and challenges.

  2018cites this paper
• Effects of methylglyoxal on RANKL-induced osteoclast differentiation in RAW264.7 cells.

  2018cites this paper
• Plasma level of protein modification and inflammatory markers in snakebite induced acute kidney injury patients undergoing haemodialysis-An observational study

  2018cites this paper
• Buckwheat bioactive compounds, their derived phenolic metabolites and their health benefits

  2017cites this paper
• Oxidative Stress in Patients Undergoing Peritoneal Dialysis: A Current Review of the Literature

  2017cites this paper
• Uremic Toxicity of Advanced Glycation End Products in CKD.

  2016cites this paper
• Linagliptin Ameliorates Methylglyoxal-Induced Peritoneal Fibrosis in Mice

  2016cites this paper
• Metody oznaczania pentozydyny - produktu zaawansowanej glikacji białekMethods of determination of pentosidine - the advanced glycation end-product of proteins

  2015cites this paper
• Fluorescence of Beta-2-microglobulin in the Spent Dialysate

  2015cites this paper
• Methods of determination of pentosidine – the advanced glycation end-product of proteins

  2015cites this paper
• Diabetic Osteopenia by Decreased β-Catenin Signaling Is Partly Induced by Epigenetic Derepression of sFRP-4 Gene

  2014cites this paper
• Classification and a List of Uremic Toxins

  2012cites this paper
• Does Dialysis Modality Influence the Oxidative Stress of Uremic Patients?

  2012cites this paper
• Protein Glycation and Eye Diseases

  2011cites this paper
• Transition Metals and Other Forms of Oxidative Protein Damage in Renal Disease

  2011cites this paper
• Rutin metabolites: novel inhibitors of nonoxidative advanced glycation end products.

  2010cites this paper
• Measurement of pentosidine in human plasma protein by a single-column high-performance liquid chromatography method with fluorescence detection.

  2009cites this paper
• Oxidative stress evaluation in uraemic patients undergoing continuous ambulatory peritoneal dialysis

  2008cites this paper
• Angiogenesis and Arteriogenesis in Diabetes Mellitus: Signal Transduction Defects as the Molecular Basis of Vascular Cell Dysfunction

  2007cites this paper
• Inactivation and modification of superoxide dismutase by glyoxal: prevention by antibodies.

  2007cites this paper
• Advanced glycation and lipoxidation end products--amplifiers of inflammation: the role of food.

  2007cites this paper
• [Advanced glycation and lipoxidation end products--amplifiers of inflammation: the role of food].

  2007cites this paper
• Methylglyoxal modification of mSin3A links glycolysis to angiopoietin-2 transcription.

  2007cites this paper
• Methylglyoxal modification of mSin3A links glycolysis to angiopoietin-2 transcription.

  2006cites this paper
• Advanced Glycation End Product Free Adducts Are Cleared by Dialysis

  2005cites this paper
• Enhanced RAGE-mediated NFkappaB stimulation in inflamed hemodialysis patients.

  2005cites this paper
• Glycation Products as Markers and Predictors of the Progression of Diabetic Complications

  2005cites this paper
• Cardiovascular risk in patients with end-stage renal disease: a potential role for advanced glycation end products.

  2005cites this paper
• Low‐Molecular Weight Advanced Glycation End Products: Markers of Tissue AGE Accumulation and More?

  2005cites this paper
• Enhanced RAGE-mediated NFκB stimulation in inflamed hemodialysis patients

  2005influential citation
• Evaluation of advanced glycation end products and carbonyl compounds in patients with different conditions of oxidative stress.

  2005cites this paper
• The Maillard Reaction in Eye Diseases

  2005cites this paper
• Accumulation of Advanced Glycation End Products, Measured as Skin Autofluorescence, in Renal Disease

  2005cites this paper
• Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry.

  2003cites this paper
• Renal clearance of glycation adducts: anti-glycation defence in uraemia and dialysis.

  2003cites this paper
• Estado nutricional y calidad de la dieta en un grupo de bailarinas en edad escolar

  2001cites this paper